| View |
|
DRP-5366-01
|
Ibuprofen + Paracetamol
|
None
|
200 mg / 325 mg
|
Tablet
|
Non-Steroidal Anti-inflammatory Drugs (NSAIDs) / Analgesic / Antipyretic
|
Brawn Laboratories Limited
|
India
|
CLIDP Conversion
|
10 October 2024
|
26 June 2029
|
| View |
|
DRP-5909-12
|
Pantoprazole (as sodium sesquihydrate)
|
Acilev
|
40mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
09 October 2024
|
12 January 2025
|
| View |
|
DRP-6260-04
|
Cetirizine Hydrochloride
|
AllerErase
|
10 mg
|
Tablet
|
Antihistamines (Piperazine Derivative)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
12 October 2024
|
03 June 2028
|
| View |
|
DRP-8392-03
|
Guaifenesin + Phenylpropanolamine HCl + Chlorphenamine Maleate + Ammonium Chloride + Sodium Citrate
|
Fermatuss
|
50mg/ 10mg/ 1mg/ 30mg/ 150mg per 5mL (cherry flavor)
|
|
Expectorant/Nasal Decongestant/Antihistamine
|
Philmed Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
10 October 2024
|
30 March 2029
|
| View |
|
DRP-13134-01
|
ASCORBIC ACID + ZINC
|
CZSAN
|
500 MG/ 15 MG
|
FILM-COATED TABLET
|
VITAMIN
|
MMC HEALTHCARE LTD.
|
India
|
CLIDP Conversion
|
04 October 2024
|
06 December 2027
|
| View |
|
DRP-10323-06
|
Etoricoxib
|
Coxsan
|
90 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-inflammatory and Antirheumatic
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
25 August 2024
|
10 September 2026
|
| View |
|
DRP-10322-08
|
Etoricoxib
|
Coxsan
|
120 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-inflammatory and Antirheumatic
|
Hiral Labs Limited
|
|
CLIDP Conversion
|
04 September 2024
|
10 September 2026
|
| View |
|
DRP-14171-05
|
Ketoanalogues + Essential Amino Acids
|
Protek-GFR
|
see reverse for formulation)
|
Film-Coated Tablet (
|
Renal Nutritional Therapy
|
4Care Lifescience Pvt. Ltd.
|
India
|
CLIDP Conversion
|
25 August 2024
|
14 July 2028
|
| View |
|
DRP-14171-06
|
Ketoanalogues + Essential Amino Acids
|
ANLOVEX
|
(see reverse for formulation)
|
Film-Coated Tablet
|
Renal Nutritional Therapy
|
4CARE LIFESCIENCE PVT. LTD
|
|
CLIDP Conversion
|
18 November 2024
|
14 July 2028
|
| View |
|
DRP-8687-05
|
Tranexamic Acid
|
Ranesan
|
100 mg / mL (500 mg / 5 mL)
|
Solution for Injection (IV)
|
Antifibrinolytic
|
Unijules Life Sciences Limited
|
India
|
CLIDP Conversion
|
04 September 2024
|
20 May 2029
|
| View |
|
DR-XY49185
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Tazolycin
|
4 g/ 500 mg
|
Powder for IV Injection
|
Combination of Penicillin, Incl. Beta-Lactamase Inhibitor
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
24 August 2024
|
29 August 2029
|